Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,843 | 1,145 | 100.0% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $2,588 | 148 | $0 (2024) |
| Novo Nordisk Inc | $1,699 | 160 | $0 (2024) |
| ViiV Healthcare Company | $1,371 | 94 | $0 (2024) |
| ABBVIE INC. | $1,326 | 94 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $913.42 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $829.06 | 49 | $0 (2024) |
| PFIZER INC. | $768.61 | 100 | $0 (2024) |
| Lilly USA, LLC | $698.76 | 53 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $685.04 | 58 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $582.51 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,874 | 92 | Gilead Sciences, Inc. ($387.69) |
| 2023 | $2,201 | 130 | ABBVIE INC. ($362.45) |
| 2022 | $1,900 | 113 | ABBVIE INC. ($308.79) |
| 2021 | $635.31 | 38 | AbbVie Inc. ($147.92) |
| 2020 | $630.57 | 40 | Gilead Sciences, Inc. ($140.85) |
| 2019 | $2,915 | 238 | Gilead Sciences, Inc. ($722.59) |
| 2018 | $3,219 | 276 | Gilead Sciences, Inc. ($505.96) |
| 2017 | $2,472 | 219 | Novo Nordisk Inc ($333.46) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: HIV | ||||||
| 11/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: HIV | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.33 | General |
| 11/01/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: HIV | ||||||
| 10/31/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: HIV | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 10/16/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: HIV | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.78 | General |
| 10/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.73 | General |
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PAIN | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.52 | General |
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 710 | 1,119 | $122,255 | $74,119 |
| 2022 | 13 | 733 | 1,066 | $130,270 | $78,119 |
| 2021 | 16 | 812 | 1,283 | $128,892 | $79,510 |
| 2020 | 16 | 776 | 1,227 | $124,425 | $64,036 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 501 | $70,140 | $40,217 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $14,850 | $12,830 | 86.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 77 | $15,862 | $9,716 | 61.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 113 | $10,170 | $5,326 | 52.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $1,650 | $1,617 | 98.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 36 | $2,340 | $1,170 | 50.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 78 | $1,170 | $742.56 | 63.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 14 | $1,120 | $588.98 | 52.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $570.00 | $558.60 | 98.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 16 | 17 | $1,513 | $496.21 | 32.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 20 | $700.00 | $438.00 | 62.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 20 | $600.00 | $194.28 | 32.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 14 | 30 | $600.00 | $126.92 | 21.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 26 | $390.00 | $57.20 | 14.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 58 | $580.00 | $38.65 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 513 | $71,820 | $41,803 | 58.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 93 | 120 | $24,720 | $14,671 | 59.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 87 | 87 | $13,050 | $11,279 | 86.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 79 | $7,110 | $3,666 | 51.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $4,176 | $2,003 | 48.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,110 | $1,088 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 21 | $1,344 | $825.01 | 61.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 39 | 39 | $1,365 | $822.51 | 60.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 80 | $1,200 | $767.16 | 63.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 14 | $1,120 | $559.78 | 50.0% |
About Dr. Michael Killian, M.D
Dr. Michael Killian, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851342026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Killian, M.D has received a total of $15,848 in payments from pharmaceutical and medical device companies, with $1,874 received in 2024. These payments were reported across 1,146 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($15,843).
As a Medicare-enrolled provider, Killian has provided services to 3,031 Medicare beneficiaries, totaling 4,695 services with total Medicare billing of $295,783. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 05/13/2006
- Last Updated 11/11/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851342026
Products in Payments
- JARDIANCE (Drug) $617.08
- Trintellix (Drug) $616.26
- FARXIGA (Drug) $544.74
- VRAYLAR (Drug) $462.85
- Victoza (Drug) $441.09
- TRELEGY ELLIPTA (Drug) $382.00
- Ozempic (Drug) $371.27
- Rybelsus (Drug) $363.93
- NURTEC ODT (Drug) $351.35
- CHANTIX (Drug) $305.26
- APRETUDE (Biological) $291.22
- DOVATO (Drug) $289.79
- Repatha (Biological) $284.85
- JULUCA (Drug) $284.18
- SYMBICORT (Drug) $268.20
- TRIUMEQ (Drug) $257.22
- MOUNJARO (Drug) $227.89
- JANUVIA (Drug) $215.73
- XARELTO (Drug) $210.20
- ADVAIR (Drug) $201.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768